DIAGNOSTICS OF PROSTATE CANCER: A 10 YEARS SYSTEMATIC REVIEW
DOI:
https://doi.org/10.61841/fzev9t17Keywords:
Prostate cancer, diagnosis, detectionAbstract
Background: Prostate cancer ranks as the second most common malignancy in men globally, following lung cancer. The present method of diagnosing prostate cancer is marked by a significant level of diagnostic uncertainty. This uncertainty has led to both overtreating and undertreating, leaving the medical community unsure about the most effective approach for prostate cancer diagnosis. This study aims to to provide a 10 year systematic review of prostate cancer diagnosis.
Methods: This systematic review adhered to the PRISMA 2020 standards and included full-text English literature published between 2014 and 2024. Exclusion criteria involved editorials, review articles from the same journal, and submissions lacking a DOI. Literature was gathered from online sources such as PubMed and SagePub.
Result: Our search in PubMed yielded 24,278 articles, while SagePub produced 5,016 articles. Focusing on the year 2014, PubMed had 270 articles, and SagePub had 502. Ultimately we selected 5 papers that met our criteria, 3 from PubMed and 2 from SagePub.
Conclusion: This study concludes that prostate cancer diagnosis can be done with biopsy in combinations to other modalities such as vibrational spectroscopy, PSA level and PSA-density, mpMRI, and biomarkers such as PCA3 and AMACR.
References
Rawla P. Epidemiology of Prostate Cancer. World J Oncol [Internet]. 2019 Apr [cited 2024 Jan 31];10(2):63–89. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497009/
Descotes JL. Diagnosis of prostate cancer. Asian Journal of Urology [Internet]. 2019 Apr 1 [cited 2024 Jan 31];6(2):129–36. Available from: https://www.sciencedirect.com/science/article/pii/S2214388219300128
Litwin MS, Tan HJ. The Diagnosis and Treatment of Prostate Cancer: A Review. JAMA [Internet]. 2017 Jun 27 [cited 2024 Jan 31];317(24):2532–42. Available from: https://doi.org/10.1001/jama.2017.7248
Gandaglia G, Leni R, Bray F, Fleshner N, Freedland SJ, Kibel A, et al. Epidemiology and Prevention of Prostate Cancer. European Urology Oncology [Internet]. 2021 Dec 1 [cited 2024 Jan 31];4(6):877–92. Available from: https://www.sciencedirect.com/science/article/pii/S2588931121001814
Ahdoot M, Wilbur AR, Reese SE, Lebastchi AH, Mehralivand S, Gomella PT, et al. MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis. N Engl J Med. 2020 Mar 5;382(10):917–28.
Medipally DKR, Cullen D, Untereiner V, Sockalingum GD, Maguire A, Nguyen TNQ, et al. Vibrational spectroscopy of liquid biopsies for prostate cancer diagnosis. Ther Adv Med Oncol [Internet]. 2020 Jan 1 [cited 2024 Jan 31];12:1758835920918499. Available from: https://doi.org/10.1177/1758835920918499
Chau EM, Russell B, Santaolalla A, Van Hemelrijck M, McCracken S, Page T, et al. MRI-based nomogram for the prediction of prostate cancer diagnosis: A multi-centre validated patient–physician decision tool. Journal of Clinical Urology [Internet]. 2023 Nov 1 [cited 2024 Jan 31];16(6):588–95. Available from: https://doi.org/10.1177/20514158211065949
Nordström T, Akre O, Aly M, Grönberg H, Eklund M. Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer. Prostate Cancer Prostatic Dis. 2018 Apr;21(1):57–63.
Ji J, Chen X, Xu Y, Cao Z, Xu H, kong C, et al. Prostate Cancer Diagnosis Using Urine Sediment Analysis-Based αMethylacyl-CoA Racemase Score: A Single-Center Experience. Cancer Control [Internet]. 2019 Jan 1 [cited 2024 Jan 31];26(1):1073274819887697. Available from: https://doi.org/10.1177/1073274819887697
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
